Free Trial

Hensoldt (OTCMKTS:HAGHY) Shares Gap Up - Time to Buy?

Hensoldt logo with background
Image from MarketBeat Media, LLC.

Key Points

  • Shares gapped up premarket from $8.83 to $9.20 but traded on extremely light volume (206 shares), suggesting the move may not reflect broad investor interest.
  • Analyst sentiment is mixed but leans positive, with three Strong Buy, one Buy, two Hold and one Sell giving an average rating of "Moderate Buy."
  • Technically the stock remains weak—the $9.20 price is well below the 50-day ($18.54) and 200-day ($37.58) moving averages, indicating a longer-term downtrend.
  • MarketBeat previews the top five stocks to own by June 1st.

Hensoldt AG - Unsponsored ADR (OTCMKTS:HAGHY - Get Free Report)'s stock price gapped up before the market opened on Monday . The stock had previously closed at $8.83, but opened at $9.20. Hensoldt shares last traded at $9.20, with a volume of 206 shares changing hands.

Wall Street Analysts Forecast Growth

HAGHY has been the topic of several research analyst reports. Zacks Research cut Hensoldt from a "hold" rating to a "strong sell" rating in a research note on Friday, March 6th. Jefferies Financial Group raised Hensoldt from a "hold" rating to a "strong-buy" rating in a research note on Sunday, March 8th. Finally, Kepler Capital Markets raised Hensoldt from a "strong sell" rating to a "hold" rating in a research note on Monday, March 16th. Three analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Hensoldt presently has an average rating of "Moderate Buy".

View Our Latest Analysis on HAGHY

Hensoldt Stock Down 2.3%

The company has a 50 day moving average of $18.54 and a 200 day moving average of $37.58.

Hensoldt Company Profile

(Get Free Report)

Hensoldt AG OTCMKTS: HAGHY is a Germany-based defense and security electronics company specializing in sensor solutions for military and civilian applications. Formed in 2017 through the spin-off of Airbus Defence and Space’s electronics division, Hensoldt has established itself as a leading provider of radar, optronics, electronic warfare systems, and command-and-control solutions. The company’s product portfolio spans airborne and naval radar systems, electro-optical and infrared (EO/IR) reconnaissance payloads, self-protection suites for aircraft and land vehicles, as well as integrated mission systems for surveillance and reconnaissance platforms.

Headquartered in Taufkirchen, near Munich, Hensoldt serves a global customer base that includes armed forces, governmental agencies, and critical infrastructure operators across Europe, the Americas, Asia-Pacific, and the Middle East.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Hensoldt Right Now?

Before you consider Hensoldt, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hensoldt wasn't on the list.

While Hensoldt currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines